Join us for the festive Bavarian evening of the ICPO Forum for Theranostics on May 15, 2025, in Garching-Munich. Don’t miss the fine local cuisine topped with Bavarian dancing entertainment. Not registered for the dinner yet? Please contact: [email protected]

🚨Last call for the ICPO Forum for Theranostics in Precision Oncology on May 15&16, 2025. Don´t miss out on sessions where global experts share their vision of targeted alpha therapies on the horizon and the related supply chain challenges: icpo-forum.org

A new milestone in theranostics education for highest quality of cancer care: ICPO launched its Observational Training at Klinikum Rechts der Isar in Munich, Germany, guided by Prof. Matthias Eiber as part of the ICPO Academy for Theranostics. More info: theranostics.academy

ICPO Forum 2025: To advance theranostics for cancer patients experts emphasized the importance of establishing clear guidelines, developing standardized clinical protocols and investing in infrastructure, international training programs and theranostics tumor boards.

Men’s Health Week: Advancing the fight against prostate cancer and neuroendocrine tumors. Listen to the ICPO patient interviews here: icpo.foundation/patient-interv…

Optimize, Educate and Certify: Learn more about the ICPO Services to Theranostics Centers and meet us at SNMMI 2025 in New Orleans on booth NP 14. (icpo.foundation)

The Lancet Regional Health - Europe, published an article with the topic: “ICPO Forum 2025: advancing theranostics in precision oncology”. Read the 7 key recommendations and the full article here: thelancet.com/journals/lanep…

🌍ICPO Foundation expands its theranostics center network in India, Jordan, and South Africa. By enhancing clinical standards these partnerships empower ICPO Centers to achieve better patient outcomes and expanding access to radiotheranostics: icpo.foundation/press-releases/

ICPO Foundation awarded Dr. Nadine Holzleitner from the Technical University of Munich (TU München ) with the Maurits W. Geerlings Next Generation Award 2025 for groundbreaking research in Actinium-225 radiopharmaceutical science. More info: icpo.foundation/press-releases/

ICPO Newsletter July 2025 is out: Dive into the latest news about our ICPO Centers, new offerings from the ICPO Academy for Theranostics, and our research projects, including an AI Research Call. icpo.foundation/fileadmin/benu…

Odile Jaume and Karim Bouterfa, (ICPO), visited Prof. Felix M. Mottaghy, Head of Nuclear Medicine Uniklinik RWTH AC & President Elect of European Association of Nuclear Medicine (EANM) . They exchanged on the current situation of theranostics centers accreditation and the opportunities of global harmonization.

ICPO and SBMN deepen their collaboration to advance Clinical Theranostics Centers of Excellence in Brazil. ICPO accreditation following international theranostics guidelines while ICPO Academy for Theranostics will fuel the partnership right from start. icpo.foundation

The ICPO Foundation welcomes Juan Davila as new Partner Engagement & Fundraising Director. With strong experience in business relationship management, Juan brings strategic foresight and international expertise to drive the growth of the ICPO Foundation.

Dr. Marwa Hakkam, ICPO Foundation, participates in the Brazilian Congress of Nuclear Medicine and Molecular Imaging in Belo Horizonte, Brazil, to present the accreditation process for the ICPO Clinical Centers of Excellence and the ICPO Academy for Theranostics.

Karim Bouterfa participates in the 23rd Annual Conference of the Association of Nuclear Medicine Physicians of India in Hyderabad, India, to present the accreditation process for the ICPO Clinical Centers of Excellence and the ICPO Academy for Theranostics at the BJ Madan booth.

Are you ready to contribute to AI transformative role in theranostics? Then don´t miss this opportunity and apply for the ICPO AI Research Grant 2025 till Nov 1, 2025. More info: icpo.foundation/icpo-research/…

The ICPO Team & members of the ICPO Community unite for Oncidium’s Tackle Cancer Challenge to raise awareness about Radiotheranostics in cancer care. Together we want to cover 50.000 km. Any sport counts! Let´s tackle cancer together from Oct 3 to 26, 2025.

New ICPO Patient Interview: Don´t miss out the interview with prostate cancer patient, Gunnar Fantoft, from Aalborg, Denmark, who has successfully undergone a treatment with Theranostics. Have a look at the entire video here: icpo.foundation/gunnar-fantoft/

ICPO visited Prof. Rudolf Werner at LMU Clinic´s Nuclear Medicine Dept in Munich. Discussions focused on theranostics growth, patient access and future collaboration along the core ICPO activities education, accreditation, research support, and innovation awareness. #LMUKlinik

We were grateful to present Kerstin Schreyer (Kerstin Schreyer) , Member of the Bavarian Parliament, the mission of the ICPO Foundation and the opportunity to be more closely connected with key partners in Bavaria in the future.